Smarter PATH
(Patent pending)
TM
Welcome to Smarter PATH™ purpose-built and driven regulatory intelligence for drug developers, point of care service providers, Private Equity and Venture Capital investors navigating complex approval landscapes.
Smarter PATH™ to Investing gives PE and VC investors the regulatory lens that financial diligence does not provide: an independent assessment of approval probability, CMC and manufacturing readiness, exclusivity architecture, and the specific gaps that separate a program worth funding from one that is carrying a CRL it doesn't yet know about.
Smarter PATH™ to REMS designs post-approval safety programs as evidence-generating, access-maximizing infrastructure, so that approval is the beginning of patient access, not another obstacle to delaying patient care.
A Powerful, three pronged framework that forms a single, continuous regulatory intelligence system: from the first investor dollar to the last post-market commitment, Smarter PATH™ ensures that the decisions that determine regulatory outcomes are made with the full picture, allowing the intelligence to forge the path.
Smarter PATH™ to Approval guides development programs from IND to BLA with the continuous, stage-specific regulatory strategy that transforms promising science into successful submissions.